TJX Companies (TJX) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
23 Nov, 2025Executive summary
Q2 net sales rose 7% year-over-year to $14.4 billion, with consolidated comp sales up 4% and store count up 3%.
Diluted EPS for Q2 was $1.10, a 15% increase year-over-year, and pre-tax profit margin improved to 11.4% from 10.9%.
Cost of sales and SG&A ratios both decreased by 0.3 percentage points, reflecting operational efficiencies.
$1 billion was returned to shareholders in Q2 via buybacks and dividends.
Strong customer transactions and business model flexibility supported results despite macro volatility.
Financial highlights
Q2 net income was $1.24 billion, up from $1.10 billion year-over-year; six-month net income was $2.28 billion.
Q2 gross profit margin was 30.7%, up 0.3 percentage points year-over-year, aided by favorable hedges.
SG&A expenses were 19.5% of sales, down 0.3 percentage points from last year due to operational efficiencies.
Operating cash flow for the first six months was $2.2 billion, with $4.6 billion in cash at period end.
Q2 cash dividends declared per share were $0.425, up from $0.375 last year.
Outlook and guidance
FY26 pre-tax profit margin guidance raised to 11.4%–11.5%; gross margin expected at 30.5%–30.7%.
FY26 diluted EPS guidance increased to $4.52–$4.57, up 6%–7% year-over-year.
Q3 FY26 comparable sales expected to rise 2%–3%; Q3 EPS guidance is $1.17–$1.19.
Capital expenditures for FY26 expected at $2.1–$2.2 billion, funded by cash and internal funds.
Guidance assumes ability to offset incremental tariff pressures and stable tariff environment.
Latest events from TJX Companies
- Record sales and profit growth, margin gains, and robust outlook with higher shareholder returns.TJX
Q4 202625 Feb 2026 - Q2 sales and profit margins exceeded expectations; FY25 guidance and global investments increased.TJX
Q2 202523 Jan 2026 - Q3 net sales up 6% to $14.1B, EPS $1.14, with raised outlook and global expansion.TJX
Q3 202513 Jan 2026 - Sales, profitability, and EPS surpassed expectations, with strong growth and expansion plans.TJX
Q4 20257 Jan 2026 - Q3 FY26 sales up 7%, EPS up 12% to $1.28, and $1.1B returned to shareholders.TJX
Q3 20262 Dec 2025 - FY25 saw robust growth, strong returns, and enhanced ESG initiatives, with all Board proposals recommended for approval.TJX
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.TJX
Proxy Filing1 Dec 2025 - Q1 FY26 sales up 5% with strong comp growth and EPS, guidance maintained despite margin pressures.TJX
Q1 202618 Nov 2025